Minot De Blois Advisors LLC Gilead Sciences, Inc. Transaction History
Minot De Blois Advisors LLC
- $100 Billion
- Q1 2025
A detailed history of Minot De Blois Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Minot De Blois Advisors LLC holds 75 shares of GILD stock, worth $8,100. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75
Previous 190
60.53%
Holding current value
$8,100
Previous $17.6 Million
52.11%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.43 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.9 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.78 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...